Condition: Diabetes Mellitus, Type 2 · Diabetic Foot · Peripheral Arterial Disease · Sponsor: HJN Sverige AB/Neko Health
The goal of this clinical investigation is to explore a non-invasive technology for measuring the microcirculatory structure, composition and function in patients from a primary care population. The main aims are: 1. To evaluate the robustness of the technology for assessment of the molecular composition and structure of the skin tissue and microcirculatory function, on a prospective primary care population. 2. To evaluate the device and method on its capability to detect deficiencies in circulation, compared with existing reference systems with similar characteristics for patients with known cardiovascular disease risk and/or diabetes.
This description comes directly from the study's public registry record.
Mattias Windå, MSc · +46703169040 · mattias@nekohealth.com
Always discuss trial participation with your own doctor first.
| Atrium Health Care Centre | Stockholm, Sweden | Recruiting |
| Neko Health Centre, Regeringsgatan | Stockholm, Sweden | Recruiting |
| Neko Health Centre, Sibyllegatan | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06976073